Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

By | July 30, 2021
Researchers in the United States have provided important insights into the antigen-specific cellular response and evolving humoral (antibody) response to messenger RNA- (mRNA) based vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).